Хронические окклюзии коронарных артерий: когда польза превышает риск?
А. Г. Бадоян,
Д. А. Хелимский,
А. А. Шермук,
О. В. Крестьянинов,
А. С. Боброва,
Ш. Ш. Фатуллоева,
А. К. Турдубаев https://doi.org/10.15829/1560-4071-2019-8-116-123
Аннотация
Лечение пациентов с хроническими окклюзиями коронарных артерий является одной из наиболее сложных проблем в интервенционной кардиологии на сегодняшний день. Это связано не только с техническими сложностями эндоваскулярной реканализации, но и сложностями отбора пациентов, у которых реваскуляризация принесёт пользу. В силу слабой доказательной базы и противоречивых результатов крупных клинических исследований, данные пациенты редко направляются на эндоваскулярную реканализацию. Целью статьи является обзор литературы и систематизация актуальных знаний по ведению пациентов с хроническими окклюзиями коронарных артерий.
Ключевые слова
Об авторах
А. Г. Бадоян
ФГБУ Национальный медицинский исследовательский центр им. акад. Е.Н. Мешалкина
Россия
Россия
Арам Гозоевич Бадоян — аспирант центра интервенционной кардиологии
Новосибирск
Д. А. Хелимский
ФГБУ Национальный медицинский исследовательский центр им. акад. Е.Н. Мешалкина
Россия
Россия
Дмитрий Александрович Хелимский — аспирант центра интервенционной кардиологии
Новосибирск
А. А. Шермук
ГБУЗ "Областная клиническая больница №1"
Россия
Россия
Артем Александрович Шермук — врач по рентгенэндоваскулярной диагностике и лечению отделение рентгенхирургических методов диагностики и лечения
Тюмень
О. В. Крестьянинов
ФГБУ Национальный медицинский исследовательский центр им. акад. Е.Н. Мешалкина
Россия
Россия
Олег Викторович Крестьянинов — кандидат медицинских наук, ведущий научный сотрудник центра интервенционной кардиологии, зав. кардиохирургическим отделением интервенционной кардиологии
Новосибирск
А. С. Боброва
ФГБУ Национальный медицинский исследовательский центр им. акад. Е.Н. Мешалкина
Анастасия Сергеевна Боброва — врач-кардиолог кардиохирургического отделения эндоваскулярной диагностики и лечения
Новосибирск
Ш. Ш. Фатуллоева
ФГБУ Национальный медицинский исследовательский центр им. акад. Е.Н. Мешалкина
Шоиста Шавкатовна Фатуллоева — клинический ординатор кардиохирургического отделения эндоваскулярной диагностики и лечения
Новосибирск
А. К. Турдубаев
Научно-исследовательский институт хирургии сердца и трансплантации органов
Кыргызстан
Кыргызстан
Абай Кубанычбекович Турдубаев — врач-кардиохирург отделения нарушений ритма сердца
Бишкек
Список литературы
1. Brilakis E. Manual of Coronary Chronic Total Occlusion Interventions: A Step-by-Step Approach. 2nd ed. Cambridge, MA: Elsevier; 2018.p.1.
2. Fefer P, Knudtson ML, Cheema AN, et al. Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry. J Am Coll Cardiol 2012;59:991 –997. doi: 10.1016/j.jacc.2011.12.007.
3. Jeroudi OM, Alomar ME, Michael TT, et al. Prevalence and management of coronary chronic total occlusions in a tertiary Veterans Affairs hospital. Catheter Cardiovasc Interv 2014;84:637 –643. doi: 10.1002/ccd.25264.
4. Hannan EL, Zhong Y, Jacobs AK, et al. Patients with chronic total occlusions undergoing percutaneous coronary interventions: characteristics, success, and outcomes. Circ Cardiovasc Interv. 2016;9:e003586. doi: 10.1161/CIRCINTERVENTIONS.116.003586.
5. Christofferson RD, Lehmann KG, Martin GV, Every N, Caldwell JH, Kapadia SR. Effect of chronic total coronary occlusion on treatment strategy. Am J Cardiol. 2005. May 1; 95 9: 1088– 91. doi: 10.1016/j.amjcard.2004.12.065
6. Sachdeva R, Agrawal M, Flynn SE, et al. The myocardium supplied by a chronic total occlusion is a persistently ischemic zone. Catheter Cardiovasc Interv. 2014;83:9-16. doi: 10.1002/ccd.25001.
7. Werner GS, Surber R, Ferrari M, et al. The functional reserve of collaterals supplying long-term chronic total coronary occlusions in patients without prior myocardial infarction. Eur Heart J. 2006;27:2406-2412. doi: 10.1093/eurheartj/ehl270
8. Franz-Josef Neumann, Miguel Sousa-Uva, Anders Ahlsson, et al. ESC Scientific Document Group; 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019 Jan 7;40(2):87-165. doi: 10.1093/eurheartj/ehy394.
9. William Wijns, Philippe Kolh, Nicolas Danchin, et al. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2010 Oct;31(20):2501-55. doi: 10.1093/eurheartj/ehq277.
10. Authors/Task Force members, Stephan Windecker, Philippe Kolh, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014 Oct 1;35(37):2541-619. doi: 10.1093/eurheartj/ehu278.
11. Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention. J Am Coll Cardiol. 2011;58:e44–e122. doi: 10.1016/j.jacc.2011.08.007.
12. Patel MR, Dehmer GJ, Hirshfeld JW et al. ACCF/ SCAI/ STS/ AATS/ AHA/ ASNC/ HFSA/SCCT 2012 Appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography. J Thorac Cardiovasc Surg. 2012 Apr;143(4):780-803. doi: 10.1016/j.jtcvs.2012.01.061.
13. Patel MR, Calhoon JH, Dehmer GJ,et al. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons. J Nucl Cardiol. 2017 Oct;24(5):1759-1792. doi: 10.1007/s12350-017-0917-9.
14. Galassi A, Grantham A, Kandzari D, et al. Percutaneous treatment of coronary chronic total occlusions. Part 1: rationale and outcomes. Interv Cardiol Rev 2014;9:195-200. doi: 10.15420/icr.2014.9.3.195
15. Suero JA, Marso SP, Jones PG, et al. Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year experience. J Am Coll Cardiol. 2001;38:409–14. doi: 10.1016/S0735-1097(01)01349-3
16. Baks T, van Geuns RJ, Duncker DJ, et al. Prediction of left ventricular function after drug-eluting stent implantation for chronic total coronary occlusions. J Am Coll Cardiol. 2006;47:721–25. doi: 10.1016/j.jacc.2005.10.042
17. Hoebers LP, Claessen BE, Elias J, et al. Meta-analysis on the impact of percutaneous coronary intervention of chronic total occlusions on left ventricular function and clinical outcome. Int J Cardiol 2015;187:90-6. doi: 10.1016/j.ijcard.2015.03.164.
18. Choi JH, Chang SA, Choi JO, et al. Frequency of myocardial infarction and its relationship to angiographic collateral flow in territories supplied by chronically occluded coronary arteries. Circulation 2013;127:703-9. doi: 10.1161/CIRCULATIONAHA.112.092353.
19. Galassi AR, Boukhris M, Toma A, et al. Percutaneous Coronary Intervention of Chronic Total Occlusions in Patients With Low Left Ventricular Ejection Fraction. JACC Cardiovasc Interv. 2017 Nov 13;10(21):2158-2170. doi: 10.1016/j.jcin.2017.06.058.
20. Toma A, Stähli BE, Gick M, et al. Comparison of Benefit of Successful Percutaneous Coronary Intervention for Chronic Total Occlusion in Patients With Versus Without Reduced (≤40%) Left Ventricular Ejection Fraction. Am J Cardiol. 2017 Nov 15;120(10):1780-1786. doi: 10.1016/j.amjcard.2017.07.088.
21. Henriques JP, Hoebers LP, Råmunddal T, et al.Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE Trial. J Am Coll Cardiol. 2016 Oct 11;68(15):1622-1632. doi: 10.1016/j.jacc.2016.07.744.
22. Mashayekhi K., Thomas G. Nührenberg, al. A Randomized Trial to Assess Regional Left Ventricular Function After Stent Implantation in Chronic Total Occlusion : The REVASC Trial. ACC: Cardiovascular Interventions Sep 2018, 3879. doi: 10.1016/j.jcin.2018.05.041.
23. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the shortterm survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003;107(23):2900–7.
24. Rossello X, Pujadas S, Serra A, et al. Assessment of Inducible Myocardial Ischemia, Quality of Life, and Functional Status After Successful Percutaneous Revascularization in Patients With Chronic Total Coronary Occlusion. Am J Cardiol. 2016 Mar 1;117(5):720-6. doi: 10.1016/j.amjcard.2015.
25. David M. Safley,Sindhu Koshy, J. Aaron Grantham, et al. Changes in Myocardial Ischemic Burden Following Percutaneous Coronary Intervention of Chronic Total Occlusions. Catheterization and Cardiovascular Interventions 78:337–343 (2011). doi: 10.1002/ccd.23002.
26. Khan MF, Wendel CS, Thai HM, Movahed MR. Effects of percutaneous revascularization of chronic total occlusions on clinical outcomes: a meta-analysis comparing successful versus failed percutaneous intervention for chronic total occlusion. Catheter Cardiovasc Interv. 2013;82:95-107. doi: 10.1002/ccd.24863.
27. Tsai TT, Stanislawski MA, Shunk KA, Armstrong EJ, Grunwald GK, Schob AH, Valle JA, Alfonso CE, Nallamothu BK, Ho PM, Rumsfeld JS, Brilakis ES. Contemporary incidence, management, and long‐term outcomes of percutaneous coronary interventions for chronic coronary artery total occlusions: insights from the VA CART program. JACC Cardiovasc Interv. 2017;10:866–875. doi: 10.1016/j.jcin.2017.02.044.
28. Hocheol Shin, Jae-Sik Jang, Han-Young Jin, et al. Impact of Successful Recanalization of Chronic Total Occlusions using Coronary Stents on Long-Term Clinical Outcomes: A Meta-Analysis. Journal of the American College of Cardiology Nov 2016, 68 (18 Supplement) B114; doi: 10.1016/j.jacc.2016.09.409
29. Christakopoulos GE, Christopoulos G, Carlino M, et al. Meta-analysis of clinical outcomes of patients who underwent percutaneous coronary interventions for chronic total occlusions. Am J Cardiol. 2015;115:1367-1375. doi: 10.1016/j.amjcard.2015.02.038
30. Ramunddal T, Hoebers LP, Henriques JP, et al. Chronic total occlusions in Sweden: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). PLoS One. 2014 Aug 12;9(8):e103850. doi: 10.1371/journal.pone.0103850.
31. Werner GS, Martin-Yuste V, Hildick-Smith D, et al. A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions. Eur Heart J. 2018 Jul 7;39(26):2484-2493. doi: 10.1093/eurheartj/ehy220.
32. Park S. Drug‐eluting stent implantation versus optimal medical treatment in patients with chronic total occlusion (DECISION‐CTO). American College of Cardiology's 66th Annual Scientific Session & Expo; Washington, DC; 2017.
33. Safley DM, Grantham JA, Hatch J,et al. Quality of life benefits of percutaneous coronary intervention for chronic occlusions. Catheter Cardiovasc Interv. 2014 Oct 1;84(4):629-34. doi: 10.1002/ccd.25303.
34. Grantham JA, Jones PG, Cannon L et al. Quantifying the early health status benefits of successful chronic total occlusion recanalization: Results from the FlowCardia's Approach to Chronic Total Occlusion Recanalization (FACTOR) Trial. Circ Cardiovasc Qual Outcomes. 2010;3:284-90. doi:10.1161/CIRCOUTCOMES.108.825760.
35. Wijeysundera HC, Norris C, Fefer P, Galbraith PD, Knudtson ML, Wolff R, Wright GA, Strauss BH and Ko DT. Relationship between initial treatment strategy and quality of life in patients with coronary chronic total occlusions. EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2014;9:1165-72. doi: 10.4244/EIJV9I10A197.
36. Olivari Z, Rubartelli P, Piscione F, et al. Immediate results and one-year clinical outcome after percutaneous coronary interventions in chronic total occlusions: data from a multicenter, prospective, observational study (TOAST-GISE). J Am Coll Cardiol. 2003 May 21;41(10):1672-8. doi: 10.1016/S0735-1097(03)00312-7.
37. Borgia F, Viceconte N, Ali O, et al. Improved cardiac survival, freedom from MACE and angina-related quality of life after successful percutaneous recanalization of coronary artery chronic total occlusions. Int J Cardiol. 2012 Nov 1;161(1):31-8. doi: 10.1016/j.ijcard.2011.04.023.
38. Bruckel JT, Jaffer FA, O'Brien C, et al. Angina severity, depression, and response to percutaneous revascularization in patients with chronic total occlusion of coronary arteries. J Invasive Cardiol. 2016;28:44–51.
39. Rossello X, Pujadas S, Serra A, et al. Assessment of inducible myocardial ischemia, quality of life, and functional status after successful percutaneous revascularization in patients with chronic total coronary occlusion. Am J Cardiol. 2016;117:720–726. doi: 10.1016/j.amjcard.2015.12.001.
40. Nombela‐Franco L, Mitroi CD, Fernandez‐Lozano I, et al. Ventricular arrhythmias among implantable cardioverter‐defibrillator recipients for primary prevention: impact of chronic total coronary occlusion (VACTO Primary Study). Circ Arrhythm Electrophysiol. 2012;5:147–154. doi: 10.1161/CIRCEP.111.968008
41. Nombela‐Franco L, Iannaccone M, Anguera I, et al. Impact of chronic total coronary occlusion on recurrence of ventricular arrhythmias in ischemic secondary prevention implantable cardioverter‐defibrillator recipients (VACTO secondary study): insights from coronary angiogram and electrogram analysis. JACC Cardiovasc Interv. 2017;10:879–888. doi: 10.1016/j.jcin.2017.02.008.
42. Raja V, Wiegn P, Obel O, et al. Impact of chronic total occlusions and coronary revascularization on all‐cause mortality and the incidence of ventricular arrhythmias in patients with ischemic cardiomyopathy. Am J Cardiol. 2015;116:1358–1362. doi: 10.1016/j.amjcard.2015.07.057.
43. Sapontis J, Salisbury AC, Yeh RW, et al. Early procedural and health status outcomes after chronic total occlusion angioplasty: a report from the OPEN‐CTO Registry (Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion Hybrid Procedures). JACC Cardiovasc Interv. 2017;10:1523–1534. doi: 10.1016/j.jcin.2017.05.065.
44. Maeremans J, Walsh S, Knaapen P, et al. The hybrid algorithm for treating chronic total occlusions in Europe: the RECHARGE Registry. J Am Coll Cardiol. 2016;68:1958–1970. doi: 10.1016/j.jacc.2016.08.034.
45. Brilakis ES, Banerjee S, Karmpaliotis D, et al. Procedural outcomes of chronic total occlusion percutaneous coronary intervention: a report from the NCDR (National Cardiovascular Data Registry). JACC Cardiovasc Interv. 2015;8:245–253. doi: 10.1016/j.jcin.2014.08.014.
46. Проспективное рандомизированное исследование реканализации хронических окклюзий коронарных артерий с использованием шкалы CHOICE. Патология кровообращения и кардиохирургия. 2018;22(4):72-79. doi:10.21688/1681-3472-2018-4-72-79
47. Tajti P, Karmpaliotis D, Alaswad K, et al. The Hybrid Approach to Chronic Total Occlusion Percutaneous Coronary Intervention: Update From the PROGRESS CTO Registry. JACC Cardiovasc Interv. 2018 Jul 23;11(14):1325-1335. doi: 10.1016/j.jcin.2018.02.036.
Рецензия
Для цитирования:
Бадоян А.Г., Хелимский Д.А., Шермук А.А., Крестьянинов О.В., Боброва А.С., Фатуллоева Ш.Ш., Турдубаев А.К. Хронические окклюзии коронарных артерий: когда польза превышает риск? Российский кардиологический журнал. 2019;(8):116-123. https://doi.org/10.15829/1560-4071-2019-8-116-123
For citation:
Badoyan A.G., Khelimsky D.A., Shermuk A.A., Krestyaninov O.V., Bobrova A.S., Fatulloeva Sh.Sh., Turdubaev A.K. Chronic coronary artery occlusion: when does the benefit outweigh the risk? Russian Journal of Cardiology. 2019;(8):116-123. (In Russ.) https://doi.org/10.15829/1560-4071-2019-8-116-123
Просмотров:
4424
Послать статью по эл. почте 